Medicus Pharma Ltd. (NASDAQ: MDCX) announced the publication of an abridged Clinical Study Report (CSR) for its SKNJCT-003 trial on ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE